Global eye care leader Alcon has reportedly entered into a strategic alliance with privately-held medical device company PowerVision, Inc. to develop fluid-based accommodating intraocular lenses (AIOL) for cataract patients.
According to the release, PowerVision focuses on developing fluid-based lens implants and has developed an AIOL that demonstrated in pilot studies the ability to change focus via a fluid-driven, shape-changing technology. Intended for use in cataract patients with presbyopia, the technology uses the eye's natural accommodating muscles to transport fluid in the intraocular lens, which is implanted in the eye's capsular bag.
Alcon's investment in PowerVision would reportedly fund further development and clinical trials, as well as provide Alcon the option to acquire the company.
Click here to read the full press release.